SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011802
Filing Date
2021-05-17
Accepted
2021-05-17 15:37:08
Documents
53
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 798787
2 ex31-1.htm EX-31.1 12066
3 ex32-1.htm EX-32.1 6926
  Complete submission text file 0001493152-21-011802.txt   3062695

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE sign-20210331.xml EX-101.INS 390253
5 XBRL SCHEMA FILE sign-20210331.xsd EX-101.SCH 29285
6 XBRL CALCULATION FILE sign-20210331_cal.xml EX-101.CAL 39335
7 XBRL DEFINITION FILE sign-20210331_def.xml EX-101.DEF 108708
8 XBRL LABEL FILE sign-20210331_lab.xml EX-101.LAB 209030
9 XBRL PRESENTATION FILE sign-20210331_pre.xml EX-101.PRE 177683
Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000
Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)

IRS No.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55575 | Film No.: 21929921
SIC: 3841 Surgical & Medical Instruments & Apparatus